Quantcast

Latest Xenomics Inc. Stories

2008-11-05 09:00:34

Xenomics, Inc. (XNOM.PK), a developer of non-invasive next-generation molecular diagnostics, announced today that it will present at the Rodman & Renshaw 10th Annual Healthcare Conference on Tuesday, November 11th in New York City. Dr. Samuil Umansky, Chief Scientific Officer of Xenomics, will provide an update on the Company's lead programs and development strategy. Rodman & Renshaw 10th Annual Healthcare Conference XNOM.PK Presentation: Tuesday, November 11th, 2008 4:05 PM...

2008-10-30 09:00:41

Xenomics, Inc. (XNOM.PK), a developer of non-invasive next-generation molecular diagnostics, announced today that it has licensed to Sequenom, Inc., a genetics and molecular diagnostics company (NASDAQ: SQNM), exclusive rights to Xenomics patents for the development of prenatal research and diagnostic products based on the Company's proprietary Transrenal DNA/RNA (Tr-DNA/RNA) technology. The agreement provides for an upfront payment, equity participation and royalties on sales of licensed...

2008-10-30 06:00:44

Sequenom, Inc. (NASDAQ: SQNM), a leading provider of molecular diagnostic applications and genetic analysis products and services, today announced that it has licensed from Xenomics, Inc. (XNOM.PK), a developer of noninvasive molecular diagnostic tests, exclusive rights to patents (U.S. Patents 6,251,638 and RE 39,920, European Patent EP 0920539) for prenatal research and diagnostic products developed using fetal nucleic acids found in maternal urine. Financial terms were not disclosed....


Word of the Day
abrosia
  • Wasting away as a result of abstinence from food.
The word 'abrosia' comes from a Greek roots meaning 'not' and 'eating'.